LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.
Chang, TG., Cao, Y., Sfreddo, H.J. et al. Nat Cancer (2024).
https://doi.org/10.1038/s43018-024-00772-7
Please adopt
Full pdf version of
Nat Cancer
[*]
[*]
[*]
. 2024 Jun 3.
doi: 10.1038/s43018-024-00772-7
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic featuresTian-Gen Chang # 1, Yingying Cao # 1, Hannah J Sfreddo # 2, Saugato Rahman Dhruba 1, Se-Hoon Lee 3, Cristina Valero 2, Seong-Keun Yoo 4 5 6, Di ...